CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
-36.21%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$42.4M
AUM Growth
+$42.4M
(-68%)
Cap. Flow
-$69.8M
Cap. Flow
% of AUM
-164.6%
Top 10 Holdings %
Top 10 Hldgs %
96.96%
Holding
13
New
1
Increased
6
Reduced
5
Closed
–
Top Buys
| 1 |
Kezar Life Sciences
KZR
|
$1.33M |
| 2 |
Adverum Biotechnologies
ADVM
|
$623K |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$585K |
| 4 |
Precision BioSciences
DTIL
|
$351K |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$234K |
Top Sells
| 1 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
$72.7M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$217K |
| 3 |
BLUE
bluebird bio
BLUE
|
$92K |
| 4 |
Ovid Therapeutics
OVID
|
$46.3K |
| 5 |
Corvus Pharmaceuticals
CRVS
|
$13K |
Sector Composition
| 1 | Healthcare | 93.95% |
| 2 | Communication Services | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORTX
1
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $22.3M | 52.57% | 2,962,267 +3,775 | +0.1% | +$28.4K |
|
|
2
Precision BioSciences
DTIL
$57.8M
| $5.67M | 13.37% | 940,560 +58,202 | +7% | +$351K |
|
|
LVGO
3
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $2.57M | 6.05% | 90,000 -2,546,640 | -97% | -$72.7M |
|
|
4
Ovid Therapeutics
OVID
$91M
| $2.47M | 5.82% | 828,413 -15,518 | -2% | -$46.3K |
|
|
BPMC
5
DELISTED
Blueprint Medicines
BPMC
| $2.11M | 4.96% | 36,000 +10,000 | +38% | +$585K |
|
|
6
Kezar Life Sciences
KZR
$28.9M
| $2M | 4.72% | 458,887 +304,632 | +197% | +$1.33M |
|
7
Ultragenyx Pharmaceutical
RARE
$2.89B
| $1.75M | 4.12% | 39,362 +862 | +2% | +$38.3K |
|
|
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $805K | 1.9% | 15,750 -4,250 | -21% | -$217K |
|
|
9
Corvus Pharmaceuticals
CRVS
$428M
| $768K | 1.81% | 364,132 -6,175 | -2% | -$13K |
|
|
MYOK
10
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $703K | 1.66% | 15,000 +5,000 | +50% | +$234K |
|
|
11
Adverum Biotechnologies
ADVM
$64.6M
| $623K | 1.47% | +63,750 | New | +$623K |
|
12
Cogent Biosciences
COGT
$1.69B
| $389K | 0.92% | 940,805 | – | – |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $276K | 0.65% | 6,000 -2,000 | -25% | -$92K |
|